KNK437, HSP70 inhibitor (TBI5561)

Description

Product Details

Formal Name: 3-(1,3-Benzodioxol-5-ylmethylene)-2-oxo-1-pyrrolidinecarboxaldehyde

Molecular Formula: C₁₃H₁₁NO₄

Formula Weight: 245.20

CAS Number: 218924-25-5

Purity: >98%

Formulation: powder

Solubility: Soluble in DMSO (30 mg/ml)

Storage: -20°C

Stability: ≥ 2 years.

 

Applications

HSP70 inhibitor

 

Functions

Inhibits constitutive and inducible HSP70 expression in non-stressed and heat-stressed cancer cells. Blocks geldanamycin-induced induction of HSP70 and inhibition of TGFß signaling. Inhibits leukocyte integrin α4ß7-mediated adhesion of T cells to mucosal addressin cell adhesion molecule 1 (MAdCAM-1), suggesting that HSP70 is essential for ß7 integrin signalling. Suppresses morphine analgesic tolerance in a rodent model (100 mg/Kg).

 

Application Procedures

First dissolved in DMSO (30 mg/ml), then diluted to aqueous buffer. Solutions in DMSO may be stored at -20°C for up to 3 months.

Additional information

SIZE (mg)	25 MG, 5 MG

Datasheet:

TBI5561_KNK437

MSDS:

TBI5561_KNK437_MSDS_2024